Recent Articles

1. Results of a Remotely Delivered Hypertension and Lipid Program in More Than 10 000 Patients Across a Diverse Health Care Network

Alexander J. Blood, MD, MSc^1,2; Christopher P. Cannon, MD^1,2; William J. Gordon, MD^2,3,4; et al Charlotte Mailly, BS⁴; Taylor MacLean, MS¹; Samantha Subramaniam, BA¹; Michela Tucci, MPH¹; Jennifer Crossen, PharmD^1,5; Hunter Nichols, PharmD^1,5; Kavishwar B. Wagholikar, MBBS, PhD⁶; David Zelle, BA¹; Marian McPartlin, BA¹; Lina S. Matta, PharmD, MPH⁵; Michael Oates⁴; Samuel Aronson, ALM, MA⁴; Shawn Murphy, MD, PhD^2,6,7,8; Adam Landman, MD^2,9; Naomi D. L. Fisher, MD^2,10; Thomas A. Gaziano, MD, MSc^1,2; Jorge Plutzky, MD^1,2; Benjamin M. Scirica, MD, MPH^1,2

JAMA Cardiol. 2023;8(1):12-21. doi:10.1001/jamacardio.2022.4018

Key Points

Question  Does an entirely remote hypertension and hypercholesterolemia program implemented across a large diverse health network help ensure equal access to care?

Findings  In this cohort study including 10 803 patients with blood pressure and/or cholesterol levels above guideline-recommended targets, remote medication titration management was significantly associated with decreased blood pressure and low-density lipoprotein cholesterol compared with education only. Similar rates of enrollment and reductions in blood pressure and low-density lipoprotein cholesterol were observed across different racial, ethnic, and primary language groups.

Meaning  These results highlight that multiple diverse populations may be treated effectively with digitally enabled remote care programs.

See Abstract